C. difficile spores are highly resistant to desiccation, chemicals and extreme temperature. Spores frequently contaminate the environment around patients with CDI, potentially persisting for ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

If you've ever dealt with diarrhea, you know how quickly it leaves you feeling depleted. Now imagine a case that rages on and on -- or comes back again and again. This is the reality for nearly ...

30 in Open Forum Infectious Diseases, analyzed 45,049 patient records from 779 hospitals of adults who received treatment for C. diff infections before and after 2021. In 2021, the Infectious ...

She led CDC activities to detect and prevent infections in healthcare settings, like C. diff, and promote healthcare safety in the United States and worldwide. Before her tenure at the CDC ...

C. diff infections cause serious and life-threatening diarrhoea and have become one of the most common microbial cause of healthcare-associated infections in US hospitals.

RBX2660 has been granted Orphan Drug status, Fast Track status and gained Breakthrough Therapy Designation from the FDA in October 2015 for its potential to prevent recurrent C. diff. infection.

New Mexico has the highest rate of Clostridium difficile infections for the second year, while Nevada has the lowest, federal data shows. The measures, developed by the CDC and collected through ...

Poo transplants are to be offered to hundreds of patients suffering from a 'superbug' to help tackle their infections. A faecal microbiota transplant (FMT) is being recommended by the National ...